Chile vs Gambia: Treatment success rate for patients treated for MDR-TB
Chile
64.0%
in 2022
Gambia
64.0%
in 2022
Chile rank
116th
Gambia rank
116th
Treatment success rate for patients treated for MDR-TB over time
- Chile
- Gambia
How they compare
Chile currently reports 64.0% against 64.0% in Gambia, a difference of 0.0%.
Across all 9 years both countries report, Gambia has been ahead every year.
Chile ranks 116th and Gambia ranks 116th of 163 countries.
Gambia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Chile | Gambia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 47.2% | 80.2% | 33.0% | Gambia |
| 2020s | 59.0% | 81.7% | 22.7% | Gambia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Chile or Gambia?
- Chile, at 64.0% against 64.0% in Gambia as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Chile and Gambia?
- 0.0%, with Chile ahead.
- How many years of comparable data are there for Chile and Gambia?
- 9 years are reported by both, from 2014 to 2022.
- How do Chile and Gambia rank globally for treatment success rate for patients treated for mdr-tb?
- Chile ranks 116th and Gambia ranks 116th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.